2023 Q3 Form 10-Q Financial Statement

#000141057823001698 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $93.52M $100.1M $128.2M
YoY Change -15.94% -21.91% 52.26%
Cost Of Revenue $85.70M $90.80M $117.9M
YoY Change -15.87% -22.99% 50.37%
Gross Profit $7.900M $9.293M $10.27M
YoY Change -15.92% -9.54% 78.04%
Gross Profit Margin 8.45% 9.28% 8.01%
Selling, General & Admin $100.0K $100.0K $13.69M
YoY Change -99.23% -99.27% 40.15%
% of Gross Profit 1.27% 1.08% 133.23%
Research & Development $1.760M $1.624M $1.048M
YoY Change 20.88% 54.96%
% of Gross Profit 22.28% 17.48% 10.2%
Depreciation & Amortization $1.599M $1.510M $1.344M
YoY Change 11.35% 12.35% 80.54%
% of Gross Profit 20.24% 16.25% 13.08%
Operating Expenses $98.90M $104.3M $15.55M
YoY Change -15.59% 570.99% -82.52%
Operating Profit -$5.372M -$4.237M -$5.275M
YoY Change -8.9% -19.68% 11.29%
Interest Expense -$100.0K -$79.00K -$6.000K
YoY Change -1009.09% 1216.67% -666.04%
% of Operating Profit
Other Income/Expense, Net -$106.0K -$83.00K -$228.0K
YoY Change -7.83% -63.6% -777.4%
Pretax Income -$5.478M -$4.320M -$5.509M
YoY Change -8.88% -21.58% 17.05%
Income Tax $18.00K $25.00K $160.0K
% Of Pretax Income
Net Earnings -$5.496M -$4.345M -$5.669M
YoY Change -8.58% -23.36% 171.06%
Net Earnings / Revenue -5.88% -4.34% -4.42%
Basic Earnings Per Share -$0.34 -$0.27 -$0.35
Diluted Earnings Per Share -$0.34 -$0.27 -$353.4K
COMMON SHARES
Basic Shares Outstanding 18.12M 18.07M 17.43M
Diluted Shares Outstanding 16.07M shares 16.02M 16.04M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.600M $9.099M $19.51M
YoY Change -54.62% -53.37% 52.07%
Cash & Equivalents $6.600M $9.100M $19.51M
Short-Term Investments
Other Short-Term Assets $10.90M $11.42M $9.300M
YoY Change -22.4% 22.75% -34.17%
Inventory
Prepaid Expenses
Receivables $4.124M $4.326M $5.020M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.64M $24.84M $33.83M
YoY Change -34.06% -26.58% 8.93%
LONG-TERM ASSETS
Property, Plant & Equipment $2.460M $2.707M $8.693M
YoY Change -21.0% -68.86% 792.96%
Goodwill $25.61M $25.61M
YoY Change 0.53%
Intangibles $24.64M $25.54M
YoY Change -11.84%
Long-Term Investments
YoY Change
Other Assets $59.00K $58.00K $50.00K
YoY Change 13.46% 16.0% -24.29%
Total Long-Term Assets $57.16M $58.84M $62.61M
YoY Change -8.07% -6.01% 27.92%
TOTAL ASSETS
Total Short-Term Assets $21.64M $24.84M $33.83M
Total Long-Term Assets $57.16M $58.84M $62.61M
Total Assets $78.80M $83.68M $96.44M
YoY Change -17.05% -13.23% 20.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.402M $4.702M $6.089M
YoY Change -30.85% -22.78% 32.08%
Accrued Expenses $3.034M $3.488M $4.334M
YoY Change -41.45% -19.52% -3.61%
Deferred Revenue
YoY Change
Short-Term Debt $6.900M $7.492M $6.129M
YoY Change 6800.0% 22.24% -34.53%
Long-Term Debt Due $290.0K $96.00K $231.0K
YoY Change -43.58% -58.44% -61.72%
Total Short-Term Liabilities $15.13M $17.40M $17.77M
YoY Change -26.87% -2.08% -27.47%
LONG-TERM LIABILITIES
Long-Term Debt $3.500M $3.427M $280.0K
YoY Change 1196.3% 1123.93% -21.53%
Other Long-Term Liabilities $312.0K $305.0K $5.642M
YoY Change -94.24% -94.59% 96.68%
Total Long-Term Liabilities $312.0K $305.0K $5.922M
YoY Change -94.51% -94.85% 1559.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.13M $17.40M $17.77M
Total Long-Term Liabilities $312.0K $305.0K $5.922M
Total Liabilities $22.99M $25.70M $23.69M
YoY Change -12.8% 8.48% -16.53%
SHAREHOLDERS EQUITY
Retained Earnings -$63.15M -$57.65M
YoY Change 67.69%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.80M $57.98M $72.75M
YoY Change
Total Liabilities & Shareholders Equity $78.80M $83.68M $96.44M
YoY Change -17.05% -13.23% 20.55%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$5.496M -$4.345M -$5.669M
YoY Change -8.58% -23.36% 171.06%
Depreciation, Depletion And Amortization $1.599M $1.510M $1.344M
YoY Change 11.35% 12.35% 80.54%
Cash From Operating Activities -$1.470M -$3.167M -$1.273M
YoY Change -78.5% 148.78% -25.67%
INVESTING ACTIVITIES
Capital Expenditures $450.0K $321.0K -$1.611M
YoY Change -158.98% -119.93% 283.42%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$907.0K
YoY Change -100.0% -89.8%
Cash From Investing Activities -$450.0K -$321.0K -$2.518M
YoY Change -41.02% -87.25% -72.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -490.0K 5.858M -7.189M
YoY Change -118.41% -181.49% -587.08%
NET CHANGE
Cash From Operating Activities -1.470M -3.167M -1.273M
Cash From Investing Activities -450.0K -321.0K -2.518M
Cash From Financing Activities -490.0K 5.858M -7.189M
Net Change In Cash -2.410M 2.370M -10.98M
YoY Change -51.21% -121.58% 14.97%
FREE CASH FLOW
Cash From Operating Activities -$1.470M -$3.167M -$1.273M
Capital Expenditures $450.0K $321.0K -$1.611M
Free Cash Flow -$1.920M -$3.488M $338.0K
YoY Change -68.4% -1131.95% -126.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001753162
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18121402
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17468562
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39412
dei Entity Registrant Name
EntityRegistrantName
FATHOM HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1518164
dei Entity Address Address Line1
EntityAddressAddressLine1
2000 Regency Parkway Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Cary
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27518
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
455-6040
dei Security12b Title
Security12bTitle
Common Stock, No Par Value
dei Trading Symbol
TradingSymbol
FTHM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18121402
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9099000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8320000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
72000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
60000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4326000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3074000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
7787000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3694000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3557000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3668000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
24841000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
18816000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2707000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2945000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4932000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5508000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25539000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27259000
CY2023Q2 us-gaap Goodwill
Goodwill
25607000
CY2022Q4 us-gaap Goodwill
Goodwill
25607000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52000
CY2023Q2 us-gaap Assets
Assets
83684000
CY2022Q4 us-gaap Assets
Assets
80187000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4702000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3343000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3488000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3403000
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7492000
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3580000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1625000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1609000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
96000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
564000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17403000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12499000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4569000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5241000
CY2023Q2 fthm Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
3427000
CY2022Q4 fthm Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
129000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
305000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
297000
CY2023Q2 us-gaap Liabilities
Liabilities
25704000
CY2022Q4 us-gaap Liabilities
Liabilities
18166000
CY2023Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18121402
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17468562
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
115631000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109626000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57651000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47605000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
57980000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
62021000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83684000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80187000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100089000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128179000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
177630000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218261000
CY2023Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
88892000
CY2022Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
116309000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
158064000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
195788000
CY2023Q2 fthm Operations And Support Expense
OperationsAndSupportExpense
1904000
CY2022Q2 fthm Operations And Support Expense
OperationsAndSupportExpense
1597000
fthm Operations And Support Expense
OperationsAndSupportExpense
3518000
fthm Operations And Support Expense
OperationsAndSupportExpense
3772000
CY2023Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1624000
CY2022Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1048000
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
2914000
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
2523000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10159000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12358000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19759000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23211000
CY2023Q2 us-gaap Marketing Expense
MarketingExpense
927000
CY2022Q2 us-gaap Marketing Expense
MarketingExpense
1329000
us-gaap Marketing Expense
MarketingExpense
1643000
us-gaap Marketing Expense
MarketingExpense
2492000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
820000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
813000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1515000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1385000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
104326000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
133454000
us-gaap Operating Expenses
OperatingExpenses
187413000
us-gaap Operating Expenses
OperatingExpenses
229171000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4237000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5275000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9783000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10910000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-79000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-63000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-228000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-163000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-564000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-234000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-226000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-571000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4320000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5509000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10009000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11481000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
185000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4345000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5669000
us-gaap Net Income Loss
NetIncomeLoss
-10046000
us-gaap Net Income Loss
NetIncomeLoss
-11666000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16023981
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16039971
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16017560
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16180782
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16023981
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16039971
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16017560
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16180782
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
59140000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3185000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4345000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
57980000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
81528000
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
263000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5057000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1681000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5669000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
72746000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
62021000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6005000
us-gaap Net Income Loss
NetIncomeLoss
-10046000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
57980000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
80150000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6168000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6045000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4139000
us-gaap Net Income Loss
NetIncomeLoss
-11666000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
72746000
us-gaap Profit Loss
ProfitLoss
-10046000
us-gaap Profit Loss
ProfitLoss
-11666000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2867000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2405000
fthm Non Cash Lease Expense
NonCashLeaseExpense
720000
fthm Non Cash Lease Expense
NonCashLeaseExpense
1098000
fthm Deferred Financing Cost Amortization
DeferredFinancingCostAmortization
21000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
1882000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
1935000
us-gaap Share Based Compensation
ShareBasedCompensation
6005000
us-gaap Share Based Compensation
ShareBasedCompensation
4348000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1252000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1461000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-111000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
152000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-80000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1359000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
787000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
369000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1092000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-800000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1074000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
85461000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
131177000
fthm Proceeds From Sale And Principal Of Mortgage Loan Held For Sale
ProceedsFromSaleAndPrincipalOfMortgageLoanHeldForSale
83250000
fthm Proceeds From Sale And Principal Of Mortgage Loan Held For Sale
ProceedsFromSaleAndPrincipalOfMortgageLoanHeldForSale
140206000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4737000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
368000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
732000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2479000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
899000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1959000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-909000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5170000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
491000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
566000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
284000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
3912000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-6886000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6045000
fthm Note Payable Loan Costs
NotePayableLoanCosts
200000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3300000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6437000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13497000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
791000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18299000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8380000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37921000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9171000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19622000
us-gaap Interest Paid Net
InterestPaidNet
21000
us-gaap Interest Paid Net
InterestPaidNet
8000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
111000
fthm Amount Due To Seller
AmountDueToSeller
1100000
fthm Capitalized Share Based Compensation Expense
CapitalizedShareBasedCompensationExpense
125000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
144000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1804000
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
6168000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9099000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19512000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
72000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
110000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9171000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19622000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Significant Risks and Business Uncertainties</i> — The Company is subject to the risks and challenges associated with companies at a similar stage of development. These include dependence on key individuals, successful development and marketing of its offerings, and competition with larger companies with greater financial, technical, and marketing resources. Furthermore, during the period required to achieve substantially higher revenue in order to become consistently profitable, the Company may require additional funds that might not be readily available or might not be on terms that are acceptable to the Company.</p>
us-gaap Net Income Loss
NetIncomeLoss
-10000000.0
us-gaap Net Income Loss
NetIncomeLoss
-11700000
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3300000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9100000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8300000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><i style="font-style:italic;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</i> — The preparation of the unaudited interim consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to doubtful accounts, legal contingencies, income taxes, deferred tax asset valuation allowances, stock-based compensation, goodwill, estimated lives of intangible assets, and intangible asset impairment. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company might differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
fthm Business Combinations Number Of Acquisitions
BusinessCombinationsNumberOfAcquisitions
2
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
35669000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10130000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25539000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34770000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7511000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27259000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2678000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
5241000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
4989000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
4353000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
3353000
CY2023Q2 fthm Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
4925000
CY2023Q2 fthm Finite Lived Intangible Assets Amortization Expense Due
FiniteLivedIntangibleAssetsAmortizationExpenseDue
25539000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
CY2023Q2 us-gaap Goodwill
Goodwill
25607000
CY2023Q2 fthm Deferred Annual Fees Current
DeferredAnnualFeesCurrent
1191000
CY2022Q4 fthm Deferred Annual Fees Current
DeferredAnnualFeesCurrent
1100000
CY2023Q2 fthm Due To Sellers
DueToSellers
573000
CY2022Q4 fthm Due To Sellers
DueToSellers
857000
CY2023Q2 fthm Accrued Compensation And Other Employer Cost
AccruedCompensationAndOtherEmployerCost
1158000
CY2022Q4 fthm Accrued Compensation And Other Employer Cost
AccruedCompensationAndOtherEmployerCost
884000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
566000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
562000
CY2023Q2 fthm Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
3488000
CY2022Q4 fthm Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
3403000
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Residual Value Guarantee
LesseeOperatingLeaseExistenceOfResidualValueGuarantee
false
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
446000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
377000
us-gaap Operating Lease Cost
OperatingLeaseCost
906000
us-gaap Operating Lease Cost
OperatingLeaseCost
709000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
141000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
115000
us-gaap Variable Lease Cost
VariableLeaseCost
302000
us-gaap Variable Lease Cost
VariableLeaseCost
227000
CY2023Q2 us-gaap Lease Cost
LeaseCost
587000
CY2022Q2 us-gaap Lease Cost
LeaseCost
492000
us-gaap Lease Cost
LeaseCost
1208000
us-gaap Lease Cost
LeaseCost
936000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0624
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0619
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1019000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1767000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1484000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1101000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
969000
CY2023Q2 fthm Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
710000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7050000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
856000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
6194000
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
10000000.0
CY2022 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
686097
CY2022 fthm Stock Repurchase Program Authorized Amount One
StockRepurchaseProgramAuthorizedAmountOne
6000000.0
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4000000.0
CY2023Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
240100
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.00
CY2023Q2 fthm Number Of Underwriters Warrants Exercised Or Expired
NumberOfUnderwritersWarrantsExercisedOrExpired
0
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3185000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1941000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6005000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4348000
CY2022Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
CY2023Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
200000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
300000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4345000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4345000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5669000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5669000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10046000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10046000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11666000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11666000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16023981
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16023981
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16039971
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16039971
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16017560
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16017560
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16180782
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16180782
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
185000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100089000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
128179000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
177630000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218261000
CY2023Q2 fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
458000
CY2022Q2 fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-1984000
fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-911000
fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-4097000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1510000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1343000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2867000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2405000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-234000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-226000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-571000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
185000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3185000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1941000
us-gaap Share Based Compensation
ShareBasedCompensation
6005000
us-gaap Share Based Compensation
ShareBasedCompensation
4348000
CY2022Q2 fthm Transaction Related Costs
TransactionRelatedCosts
7000
fthm Transaction Related Costs
TransactionRelatedCosts
60000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4345000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5669000
us-gaap Net Income Loss
NetIncomeLoss
-10046000
us-gaap Net Income Loss
NetIncomeLoss
-11666000
CY2023Q2 fthm Cash Balance Commitment Amount
CashBalanceCommitmentAmount
700000
CY2022Q4 fthm Cash Balance Commitment Amount
CashBalanceCommitmentAmount
1800000

Files In Submission

Name View Source Status
0001410578-23-001698-index-headers.html Edgar Link pending
0001410578-23-001698-index.html Edgar Link pending
0001410578-23-001698.txt Edgar Link pending
0001410578-23-001698-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fthm-20230630.xsd Edgar Link pending
fthm-20230630x10q.htm Edgar Link pending
fthm-20230630xex31d1.htm Edgar Link pending
fthm-20230630xex31d2.htm Edgar Link pending
fthm-20230630xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
fthm-20230630_cal.xml Edgar Link unprocessable
fthm-20230630_def.xml Edgar Link unprocessable
fthm-20230630_lab.xml Edgar Link unprocessable
fthm-20230630_pre.xml Edgar Link unprocessable
fthm-20230630x10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable